ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR BIOSIMILARS IN OPHTHALMOLOGY

Anti–vascular endothelial growth factor therapies have proven effective in treating retinal diseases but come with a high financial burden to the patient and health care system. Biosimilar drugs present an opportunity to decrease the cost of these important ophthalmic medications, and several ophtha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaiser, Peter K., Schmitz-Valckenberg, Marc Steffen, Holz, Frank G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665947/
https://www.ncbi.nlm.nih.gov/pubmed/36394884
http://dx.doi.org/10.1097/IAE.0000000000003626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665947/
https://www.ncbi.nlm.nih.gov/pubmed/36394884
http://dx.doi.org/10.1097/IAE.0000000000003626

Ejemplares similares